CHEK2 and breast cancer: Inheritance of a CHEK2 protein-truncating mutation such as the relatively well investigated Northern European founder mutation c.1100delC confers a two- to threefold increased risk of breast cancer, an increased risk of a number of other cancer types and perhaps a decreased risk of some smoking-related cancers [9,19-21].